- Home
- NWBI vs TXG Comparison
NWBI vs TXG Comparison
Compare NWBI & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWBI
- TXG
- Stock Information
- Founded
- NWBI 1896
- TXG 2012
- Country
- NWBI United States
- TXG United States
- Employees
- NWBI 2099
- TXG N/A
- Industry
- NWBI Major Banks
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- NWBI Finance
- TXG Industrials
- Exchange
- NWBI Nasdaq
- TXG Nasdaq
- Market Cap
- NWBI 1.8B
- TXG 1.7B
- IPO Year
- NWBI N/A
- TXG 2019
- Fundamental
- Price
- NWBI $12.66
- TXG $14.15
- Analyst Decision
- NWBI Hold
- TXG Buy
- Analyst Count
- NWBI 1
- TXG 11
- Target Price
- NWBI $15.00
- TXG $13.41
- AVG Volume (30 Days)
- NWBI 918.3K
- TXG 3.0M
- Earning Date
- NWBI 10-28-2025
- TXG 08-07-2025
- Dividend Yield
- NWBI 6.33%
- TXG N/A
- EPS Growth
- NWBI 39.35
- TXG N/A
- EPS
- NWBI 1.12
- TXG N/A
- Revenue
- NWBI $561,855,000.00
- TXG $644,466,000.00
- Revenue This Year
- NWBI $7.67
- TXG $1.75
- Revenue Next Year
- NWBI $16.05
- TXG N/A
- P/E Ratio
- NWBI $11.28
- TXG N/A
- Revenue Growth
- NWBI 14.22
- TXG 2.02
- 52 Week Low
- NWBI $10.75
- TXG $6.78
- 52 Week High
- NWBI $15.42
- TXG $24.76
- Technical
- Relative Strength Index (RSI)
- NWBI 57.97
- TXG 60.94
- Support Level
- NWBI $12.57
- TXG $13.81
- Resistance Level
- NWBI $12.77
- TXG $14.57
- Average True Range (ATR)
- NWBI 0.23
- TXG 0.64
- MACD
- NWBI 0.11
- TXG 0.06
- Stochastic Oscillator
- NWBI 90.91
- TXG 86.12
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).